- Dry Eye
Results from COMET-4: A Long-Term (12mo.) Safety Study of Acoltremon Ophtalmologic Solution 0.003%
May 20, 2025
This video presents 12-month safety outcomes from the COMET-4 study evaluating Acoltremon, focusing on long-term tolerability and clinical implications for managing myopia progression.